Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

医学 临床试验 放射治疗 肿瘤科 内科学 德尔菲法 疾病 医学物理学 重症监护医学 数学 统计
作者
Matthias Gückenberger,Yolande Lievens,Angelique B. Bouma,Laurence Collette,André Dekker,Nandita M. deSouza,Anne‐Marie C. Dingemans,Béatrice Fournier,Coen Hurkmans,Frédéric Lecouvet,Icro Meattini,Alejandra Romero,Umberto Ricardi,Nicola S. Russell,Daniel H. Schanne,Marta Scorsetti,Bertrand Tombal,Dirk Verellen,Christine Verfaillie,Piet Ost
出处
期刊:Lancet Oncology [Elsevier BV]
卷期号:21 (1): e18-e28 被引量:1011
标识
DOI:10.1016/s1470-2045(19)30718-1
摘要

Summary

Oligometastatic disease has been proposed as an intermediate state between localised and systemically metastasised disease. In the absence of randomised phase 3 trials, early clinical studies show improved survival when radical local therapy is added to standard systemic therapy for oligometastatic disease. However, since no biomarker for the identification of patients with true oligometastatic disease is clinically available, the diagnosis of oligometastatic disease is based solely on imaging findings. A small number of metastases on imaging could represent different clinical scenarios, which are associated with different prognoses and might require different treatment strategies. 20 international experts including 19 members of the European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer OligoCare project developed a comprehensive system for characterisation and classification of oligometastatic disease. We first did a systematic review of the literature to identify inclusion and exclusion criteria of prospective interventional oligometastatic disease clinical trials. Next, we used a Delphi consensus process to select a total of 17 oligometastatic disease characterisation factors that should be assessed in all patients treated with radical local therapy for oligometastatic disease, both within and outside of clinical trials. Using a second round of the Delphi method, we established a decision tree for oligometastatic disease classification together with a nomenclature. We agreed oligometastatic disease as the overall umbrella term. A history of polymetastatic disease before diagnosis of oligometastatic disease was used as the criterion to differentiate between induced oligometastatic disease (previous history of polymetastatic disease) and genuine oligometastatic disease (no history of polymetastatic disease). We further subclassified genuine oligometastatic disease into repeat oligometastatic disease (previous history of oligometastatic disease) and de-novo oligometastatic disease (first time diagnosis of oligometastatic disease). In de-novo oligometastatic disease, we differentiated between synchronous and metachronous oligometastatic disease. We did a final subclassification into oligorecurrence, oligoprogression, and oligopersistence, considering whether oligometastatic disease is diagnosed during a treatment-free interval or during active systemic therapy and whether or not an oligometastatic lesion is progressing on current imaging. This oligometastatic disease classification and nomenclature needs to be prospectively evaluated by the OligoCare study.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
啊啊完成签到,获得积分10
刚刚
ing发布了新的文献求助10
1秒前
zero发布了新的文献求助10
1秒前
1秒前
默默发布了新的文献求助10
1秒前
kobe完成签到,获得积分10
2秒前
ty12390完成签到,获得积分10
2秒前
闪闪的灵发布了新的文献求助10
2秒前
Akim的应助被蝴蝶结教教主采纳,获得10
3秒前
无名之辈发布了新的文献求助200
3秒前
摸鱼大王发布了新的文献求助10
3秒前
3秒前
3秒前
04d的应助被内向易文采纳,获得10
4秒前
4秒前
4秒前
顺顺利利的应助被不安鱼采纳,获得10
4秒前
5秒前
5秒前
6秒前
Firsterchao发布了新的文献求助100
6秒前
K神发布了新的文献求助10
6秒前
Owen的应助被义气的青枫采纳,获得10
6秒前
王仙开完成签到,获得积分10
7秒前
sunnymoon发布了新的文献求助10
7秒前
7秒前
wjx发布了新的文献求助10
7秒前
xxxxx的应助被迷你的向日葵采纳,获得40
8秒前
研友_8QqdO8完成签到,获得积分10
8秒前
欧文发布了新的文献求助10
8秒前
小太阳发布了新的文献求助10
8秒前
外向书萱发布了新的文献求助10
8秒前
深情安青的应助被Clarissa采纳,获得10
9秒前
奔跑的应助被车访枫采纳,获得10
9秒前
9秒前
tph发布了新的文献求助10
9秒前
9秒前
余香的应助被forge采纳,获得10
11秒前
Xiaojiu完成签到 ,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8161554
求助须知:如何正确求助?哪些是违规求助? 9556174
关于积分的说明 21732775
捐赠科研通 7751537
什么是DOI,文献DOI怎么找? 3427556
关于科研通互助平台的介绍 2552588
邀请新用户注册赠送积分活动 2472023